Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score® to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Greater Precision

Press/Media

Period	3 Jun 2019

Media coverage

Title	Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score® to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Greater Precision
Media name/outlet	Yahoo! Finance
Country/Territory	United States
Date	3/06/19
URL	https://finance.yahoo.com/news/secondary-analysis-landmark-tailorx-results-154500797.html
Persons	Joseph Sparano